Harm Reduction Journal

Papers
(The median citation count of Harm Reduction Journal is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Expanding single-venue services to better engage young people who inject drugs: insights from India78
Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment64
The acceptability of overdose alert and response technologies: introducing the TPOM-ODART framework53
Acceptability of supervised injection facilities among persons who inject drugs in upstate New York52
Experiences of harm and mental ill-health among gay, bisexual and other men-who-have-sex-with-men who use methamphetamine or GHB/GBL in different combinations: findings from the COMeT study in Taiwan48
Associations with experience of non-fatal opioid overdose in British Columbia, Canada: a repeated cross sectional survey study47
Moving from ‘stigma reduction’ to ‘inclusion’: development of the inclusion collaborative at Nepean Blue Mountains Local Health District, New South Wales44
The impact of institutionalization on the effectiveness of harm reduction: a qualitative study using drug users’ representations42
HIV risk and prevention among clients of a delivery-based harm reduction service during an HIV outbreak among people who use drugs in northern rural Minnesota, USA41
“The people who depended on us became expendable”: Experiences of frontline workers with lived and living expertise of drug use during the COVID-19 pandemic41
Welfare first: transforming harm reduction at UK festivals40
Contamination of a drug consumption room with drugs and potential risks for social health care workers39
Egocentric network characteristics of people who inject drugs in the Chicago metro area and associations with hepatitis C virus and injection risk behavior38
Drug decriminalization: a co-designed study outlining the implications for providers of youth services38
Examining rural community pharmacists’ knowledge and practices in opioid overdose prevention and treatment services in the Southeastern United States37
Exploring perceived quality of life in long-term methadone-dependent patients: a qualitative study34
Willingness to use and distribute HIV self-testing kits among people who inject drugs in the San Diego–Tijuana border region33
Decentralized HIV testing: comparing peer and mail-based distribution strategies to improve the reach of HIV self-testing among people who use drugs in Florida32
A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City32
Assessment of two brands of fentanyl test strips with 251 synthetic opioids reveals “blind spots” in detection capabilities31
Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review30
Harm reduction in substance use: perspectives and experiences of community volunteers and student interns in Durban, South Africa29
Barriers to uptake of harm reduction techniques for GBMSM who use drugs in night-clubs and sex-on-premises venues in London and the Southeast: a mixed-methods, qualitative study29
Is fentanyl in everything? Examining the unexpected occurrence of illicit opioids in British Columbia’s drug supply28
Houselessness and syringe service program utilization among people who inject drugs in eight rural areas across the USA: a cross-sectional analysis28
Vaping among Norwegians who smoke or formerly smoked: reasons, patterns of use, and smoking cessation activity28
Improving access to HIV care among people who inject drugs through tele-harm reduction: a qualitative analysis of perceived discrimination and stigma28
“Naloxone? Not for me!” First cross-assessment by patients and healthcare professionals of the risk of opioid overdose28
“Expected to happen”: perspectives on post-release overdose from recently incarcerated people with opioid use disorder28
“To not feel fake, it can’t be fake”: co-creation of a harm reduction, peer-delivered, health-system intervention for people who use drugs28
The war on drugs is a war on us: young people who use drugs and the fight for harm reduction in the Global South27
First results of the French OCTOPUS survey among festival attendees: a latent class analysis27
Will the Russian war in Ukraine unleash larger epidemics of HIV, TB and associated conditions and diseases in Ukraine?27
Online interventions and virtual day centres for young people who use drugs: potential for harm reduction?26
Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative26
One voice and vision: How the RISE network built a collective identity as the foundation for strategic dissemination25
Substance use stigma reduces trust and informational support: experimental evidence across risk and relationship contexts25
The implementation of safer drug consumption facilities in Scotland: a mixed methods needs assessment and feasibility study for the city of Edinburgh25
Facilitators of and obstacles to practitioners’ adoption of harm reduction in cannabis use: a scoping review24
Assessing the feasibility, acceptability and accessibility of a peer-delivered intervention to reduce harm and improve the well-being of people who experience homelessness with problem substance use: 24
Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study24
Integration of a community-based harm reduction program into a safety net hospital: a qualitative study24
Correction: Non-injection drug use among incarcerated people in Iran: Findings from three consecutive national bio-behavioral surveys23
Channelling and taxation in European online gambling markets: evolution and policy implications23
Willingness to use syringe services programs in a Northern Midwest American Indian community23
Puff, Puff, Don’t Pass: harm reduction for cannabis use during a viral respiratory pandemic22
Use and perceptions of Cannabidiol among individuals in treatment for opioid use disorder22
Feeling safer: effectiveness, feasibility, and acceptability of continuous pulse oximetry for people who smoke opioids at overdose prevention services in British Columbia, Canada22
Harm reduction behaviours and harm experiences of people who use 3,4-methylenedioxymethamphetamine (MDMA) in Aotearoa New Zealand22
Challenges for drug checking services in Scotland: a qualitative exploration of police perceptions22
Practical guidance for navigating buprenorphine discontinuation22
“There are only so many fires you can put out”: nonprofit structural constraints on service delivery for pregnant and postpartum women who use drugs in Appalachian North Georgia21
Factors associated with gaps in naloxone knowledge: evidence from a 2022 great plains survey21
Service utilization patterns and characteristics among clients of integrated supervised consumption sites in Toronto, Canada21
Patient perspectives on naloxone receipt in the emergency department: a qualitative exploration21
Counting the vulnerable: estimating the population size and assessing the HIV care continuum among women who inject drugs in Southern Mozambique21
Change in substance use among patients in opioid maintenance treatment: baseline to 1-year follow-up21
One-month alcohol abstinence national campaigns: a scoping review of the harm reduction benefits21
Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A prospective cohort study21
“They won’t prosecute, but they will though:” the continuing struggle between criminalization and harm reduction within the criminal justice system in the context of an opioid overdose crisis20
Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study20
Feasibility of paying people who use drugs cash to distribute naloxone within their networks20
A systematic review of interventions that impact alcohol and other drug-related harms in licensed entertainment settings and outdoor music festivals20
Prevalence of HIV and Hepatitis C and access to opioid substitution treatment among people who inject drugs in three cities in Croatia: findings from the second wave of respondent-driven sampling surv19
Reducing medical cannabis use risk among Veterans: A descriptive study19
BeHERE’s effective virtual training to build capacity to support people who use drugs in non-substance use disorder settings19
Correction: Developing a comprehensive inventory to define harm reduction housing18
Not all screens are created equal: examination of surface features and other physical properties of commonly used screen materials for smoking drugs18
An evaluation of first responders’ intention to refer to post-overdose services following SHIELD training18
Total systems failure: police officers’ perspectives on the impacts of the justice, health, and social service systems on people who use drugs18
Best practices for community-based overdose education and naloxone distribution programs: results from using the Delphi approach18
Assessing healthcare cost changes associated with transitioning away from cigarette smoking using healthcare claims data: an exploratory study among adult male patients with COPD18
“It’s just what’s around these days”: social and contextual pragmatism in substance transitions18
Analysis of different populations accessing online overdose response training and harm reduction supplies (ADORES)18
“They make it too hard and too many hoops to jump”: system and organizational barriers to drug treatment during epidemic rates of opioid overdose18
Anabolic-androgenic steroid testing as a tool for consumer engagement and harm reduction: a sequential explanatory mixed-method study17
Effects of a social network intervention on HIV seroconversion among people who inject drugs in Ukraine: moderation by network gender composition17
Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER)17
International harm reduction indicators are still not reached: results from a repeated cross-sectional study on drug paraphernalia distribution in Germany, 202117
The impact of supported accommodation on health and criminal justice outcomes of people released from prison: a systematic literature review17
The joy and pain of being a harm reduction worker: a qualitative study of the meanings about harm reduction in Brazil17
Structural stigma within inpatient care for people who inject drugs: implications for harm reduction17
Involuntary discharge from drug or alcohol treatment programs in Vancouver, Canada17
Correction: The managers’ perspectives on service providing in women’s harm reduction centers during the COVID-19 pandemic: mixed method study17
Prevalence and predictors of condom use among people who inject drugs in Georgia16
Challenges in legitimizing further measures against smoking in jurisdictions with robust infrastructure for tobacco control: how far can the authorities allow themselves to go?16
The association between cannabis use and adherence to COVID-19 public health guidelines: prospective analyses from the French CONSTANCES cohort and SAPRIS survey16
Predictors of concurrent heroin use among patients on opioid maintenance treatment in France: a multilevel study over 11 years16
“I feel like marijuana is the only drug that wouldn’t kill me”: perceptions of cannabis use in previously incarcerated Black men who have sex with other men16
Setting foot in private spaces: extending the hepatitis C cascade of care to automatic needle/syringe dispensing machines, a mixed methods study16
'It’s not going to be a one size fits all': a qualitative exploration of the potential utility of three drug checking service models in Scotland15
Doctors’ and pharmacists’ perspectives on the clinical use of medicinal Cannabis: a cross-sectional study15
Microbiological contamination in androgens from the black market15
Supervised consumption site enables cost savings by avoiding emergency services: a cost analysis study15
HIV vaulnerability among people who inject drugs (PWID): findings from the Bangladesh integrated biological and behavioural surveillance (IBBS) study 202015
Creating safe, inclusive spaces for hospital-based health care staff and people who use drugs: an exploratory qualitative study in Vancouver, Canada15
Feasibility, acceptability, and perceived usefulness of a community-evidence-based harm reduction intervention for sexualized stimulant use among Mexican gay, bisexual, and other men who have sex with15
Quantifying the size and characteristics of a population of people who use drugs on the reservation lands of a tribal nation in the southern plains (USA)14
The associations between social determinants of health, mental health, substance-use and recidivism: a ten-year retrospective cohort analysis of women who completed the connections programme in Austra14
Development, acceptability and feasibility of a personalised, behavioural intervention to prevent bacterial skin and soft tissue infections among people who inject drugs: a mixed-methods Person-Based 14
Scaling up low barrier wound care for people who use drugs: a mixed methods study14
Correction: Economic evaluation of the effect of needle and syringe programs on skin, soft tissue, and vascular infections in people who inject drugs: a microsimulation modelling approach14
Heroin pipe distribution to reduce high-risk drug consumption behaviors among people who use heroin: a pilot quasi-experimental study14
The potential use of digital technologies to enhance opioid agonist treatment in rural and remote communities of British Columbia, Canada14
The “goldfish bowl”: a qualitative study of the effects of heightened surveillance on people who use drugs in a rural and coastal Canadian setting14
Injecting drugs alone during an overdose crisis in Vancouver, Canada14
“I don’t let anybody die on my watch”: perspectives on the intersection of community overdose response and emergency medical services among people who use drugs in Seattle, WA14
Ultrasound-guided phlebotomy in primary care for people who inject drugs14
Switching behavior and changes in smoking behavior by menthol cigarette preference and menthol heated tobacco product use among adults in the United States who smoke cigarettes: an actual use study14
Law enforcement and syringe services program implementation in rural counties in Kentucky: a qualitative exploration14
Managing high-risk behaviours and challenges to prevent housing loss in permanent supportive housing: a rapid review14
Correction: A reduced exposure heated tobacco product was introduced then abruptly taken off United States shelves: results from a tobacco harm reduction natural experiment14
50 years of harm reduction in Europe: high time for transformation14
Are you tripping comfortably? Investigating the relationship between harm reduction and the psychedelic experience14
Gambling treatment service providers’ views about contingency management: a thematic analysis13
Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review13
Differentiating the role of alcohol in young men’s use of substances with sex: A qualitative study13
Oral health risks in adults who use electronic nicotine delivery systems and oral nicotine pouches: a critical review of the literature and qualitative synthesis of the available evidence13
Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community13
Sterile syringe availability in Georgia pharmacies remained rare, despite policy change permitting sales13
Perspectives of U.S. harm reduction advocates on persuasive message strategies13
Uptake of COVID-19 vaccination among people who inject drugs13
How an emergency department is organized to provide opioid-specific harm reduction and facilitators and barriers to harm reduction implementation: a systems perspective13
Developing and testing a digital harm reduction app for GBMSM engaging in chemsex: a feasibility study grounded in users' lived experiences13
Come back when you’re infected: pharmacy access to sterile syringes in an Arizona Secret Shopper Study, 202312
Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review12
Preloading with drugs before entry to the nighttime entertainment district: presentation, intoxication rates, and effects of police presence during assessment12
The potential of new nicotine and tobacco products as tools for people who smoke to quit combustible cigarettes – a systematic review of common practices and guidance towards a robust study protocol t12
“We were building the plane as we were flying it, and we somehow made it to the other end”: syringe service program staff experiences and well-being during the COVID-19 pandemic12
Xylazine co-occurrence with illicit fentanyl is a growing threat in the Deep South: a retrospective study of decedent data12
High prevalence of hepatitis B virus susceptibility among persons undergoing community-based hepatitis C virus treatment12
Correction: Health workers’ perspectives of hepatitis B-related stigma among Aboriginal and Torres Strait Islander people in New South Wales, Australia12
The motives and methods of methamphetamine and ‘heroin’ co-use in West Virginia12
NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users12
A scoping review on barriers and facilitators to harm reduction care among youth in British Columbia, Canada12
Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: a retrospective cohort study12
Exploring substance use disorder discussions in Native American communities: a retrospective Twitter infodemiology study12
‘We don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts12
Informed implementation practice – formative research of a mobile drug consumption room in Brno, Czech Republic12
The high frequency of alcohol advertising during televised English Premier League football games shown in Ethiopia11
Social justice with harm reduction approaches for mothers who use opioids: an international comparative ethnographic study with community engaged methods11
Challenges of the COVID-19 pandemic on women’s HIV harm reduction centers: a mixed-methods study11
Relational anonymity in reducing the harms of illicit drug use: accounts of users of dark web- and street-based services in Finland11
“I don’t want to die”: a qualitative study of coping strategies to prevent fentanyl-related overdose deaths among people who inject drugs and its implications for harm reduction policies11
A Case report of a continuous ambulatory drug delivery (CADD) pump to deliver opioid agonist treatment in an acute care setting11
Challenges for the implementation of injectable opioid agonist treatment: a scoping review11
“We want everything in a one-stop shop”: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs11
The challenges, opportunities and strategies of engaging young people who use drugs in harm reduction: insights from young people with lived and living experience11
Understanding Vietnam’s drug policy for amphetamine-type stimulants misuse11
The impact of JUUL market entry on cigarette sales: evidence from a major chain retailer in Canada11
HIV prevalence and continuum of care among incarcerated people in Iran from 2010 to 201711
Diverse psychotropic substances detected in drug and drug administration equipment samples submitted to drug checking services in Toronto, Ontario, Canada, October 2019–April 202011
The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study11
A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa11
The quality of health information provided on web sites selling cannabis to consumers in Canada is poor11
“We knew it was coming: we didn’t act” perspectives from people who use drugs and substance use workforce on the impact of delays in implementation of the supervised injection facility and drug checki10
Supporting syringe services programs in the initiation and scale-up of vaccine administration: findings from in-depth interviews10
The relationship between police contacts for drug use-related crime and future arrests, incarceration, and overdoses: a retrospective observational study highlighting the need to break the vicious cyc10
Selling sex in the context of substance use: social and structural drivers of transactional sex among men who use opioids in Maryland10
Differences by race and ethnicity in drug use patterns, harm reduction practices and barriers to treatment among people who use drugs in Rhode Island10
Patient perceptions of and experiences with stigma using telehealth for opioid use disorder treatment: a qualitative analysis10
Bigger than sport: the enhanced games and the commodification of telehealth, testosterone, and dependency10
SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya10
Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019–2021: a repeat cross-sectional study10
Progress and challenges in the elimination of hepatitis C among people who inject drugs in Germany: results of a pilot study for a national monitoring system, 10 years after the first data collection10
Posttraumatic stress disorder in people who use drugs: syringe services program utilization, treatment need, and preferences for onsite mental health care10
Impact of Spanish gambling regulations on online gambling behavior and marketing strategies10
Opioid overdose prevention education in Texas during the COVID-19 pandemic10
Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study10
Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study10
Vancouver’s Alcohol Knowledge Exchange: lessons learned from creating a peer-involved alcohol harm reduction strategy in Vancouver’s Downtown Eastside10
Signals of increasing co-use of stimulants and opioids from online drug forum data10
Exploring the perception of key stakeholders toward khat policy approaches in Ethiopia: a qualitative study10
Correction: Reducing the harms of xylazine: clinical approaches, research deficits, and public health context10
Nurse prescribing practices across the globe for medication-assisted treatment of the opioid use disorder (MOUD): a scoping review9
Cohort profile: the Kyrgyzstan InterSectional Stigma (KISS) injection drug use cohort study9
Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples9
Muslims perceptions of safe alcohol use: a qualitative study in the Gulf Council Cooperation countries9
Comprehensive drug policies increase trust in local government: an analysis of authorities’ and residents’ perspectives in rural US Appalachian and Midwestern counties9
Philanthropic donor perspectives about providing harm reduction services for people living with HIV/AIDS in a hospital setting9
Common data elements for criminal legal system involvement for people who use drugs9
Patterns of care contacts in the final year of life among opioid overdose fatalities in southern Sweden: a latent class analysis9
Managing risks and harms associated with the use of anabolic steroids: a qualitative study9
Women, gender and drugs: between research and action9
Mandatory verses voluntary self-tests for new online casino customers: effect on engagement, quality, gambling behavior and use of responsible gambling measures9
Reducing the harms of cannabis use in youth post-legalization: insights from Ontario youth, parents, and service providers9
Overdose responses among rural people who use drugs: A multi-regional qualitative study9
The impact of psychostimulant use on office based buprenorphine treatment retention9
Point-of-care community drug checking technologies: an insider look at the scientific principles and practical considerations9
Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities9
“Because we’re the experts”: centering the expertise of people who use drugs to identify and propose solutions for overdose prevention9
Community pharmacists’ attitudes toward and practice of pharmacy-based harm reduction services in Pittsburgh, PA: a descriptive survey8
“No-one just does drugs during business hours!”: evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia8
An exploration of desired abstinent and non-abstinent recovery outcomes among people who use methamphetamine8
Neo-colonialism and financing for the war on drugs: a review of current policy and recommendations for countries in the global north8
Supervised on-site dosing in injectable opioid agonist treatment-considering the patient perspective. Findings from a cross-sectional interview study in two German cities8
COVID-19 vaccination intention among people who use drugs in France in 2021: results from the international community-based research program EPIC8
Suicidal thoughts and behaviors among untreated illicit substance users: a population-based study8
Dealing with low access to harm reduction: a qualitative study of the strategies and risk environments of people who use drugs in a small Swedish city8
A scoping review of implementation considerations for harm reduction vending machines8
Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022–2023 (CAMS-22)8
‘Why would we not want to keep everybody safe?’ The views of family members of people who use drugs on the implementation of drug consumption rooms in Scotland8
A cultural and political difference: comparing the racial and social framing of population crack cocaine use between the United States and France8
Ups and downs of addiction harm reduction in Iran: key insights and implications for harm reduction policy and policing8
A longitudinal study of naloxone opioid overdose awareness and reversal training for first-year medical students: specific elements require reinforcement8
Implementing Canada’s first national virtual phone based overdose prevention service: lessons learned from creating the National Overdose Response Service (NORS)8
Repeated point-prevalence of switching away from smoking after electronic nicotine delivery systems (ENDS) purchase8
Association between socioeconomic and motherhood characteristics with receiving community-based treatment services among justice-involved young female drug users: a retrospective cohort study in Taiwa8
Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive ev8
A confirmed case of xylazine-induced skin ulcers in a person who injects drugs in Miami, Florida, USA8
“As safe as possible”: a qualitative study of opioid withdrawal and risk behavior among people who use illegal opioids8
Innovations at the intersection of homelessness and substance use during the COVID-19 pandemic: a scoping review8
Peer research with populations of people who use street tablets in areas over-represented by drug-related harms in the UK: a case study8
Substance use, injection risk behaviors, and fentanyl-related overdose risk among a sample of PWID post-Hurricane Maria8
CENTER-ing Black voices: incorporating lived experience across the research process to advance equity in drug treatment and outcomes8
A randomised, crossover, clinical study to assess nicotine pharmacokinetics and subjective effects of the BIDI® stick ENDS compared with combustible cigarettes and a comparator ENDS in adult smokers7
Intention to get naloxone among patients prescribed opioids for chronic pain7
Correlates of fentanyl preference among people who use drugs in Rhode Island7
Correction: Assessing feasibility of a modified same-day test-and-treat model for hepatitis C among rural people who inject drugs7
An individual-based dynamic model to assess interventions to mitigate opioid overdose risk7
Low-dose overlap initiation with split tablets of buprenorphine in intubated intensive care unit patients with opioid use disorder7
Fanning the flame: analysing the emergence, implications, and challenges of Australia’s de facto war on Nicotine7
The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-197
Estimating lung cancer risk from e-cigarettes and heated tobacco products: applications of a tool based on biomarkers of exposure and of potential harm7
People who inject oral morphine favor experimentation with injectable opioid substitution7
Difficulty accessing supervised consumption services during the COVID-19 pandemic among people who use drugs in Vancouver, Canada7
Economic evaluation of the effect of needle and syringe programs on skin, soft tissue, and vascular infections in people who inject drugs: a microsimulation modelling approach7
Self-exclusion and breaching of self-exclusion from gambling: a repeated survey study on the development of a nationwide self-exclusion service7
Drug preparation, injection-related infections, and harm reduction practices among a national sample of individuals entering treatment for opioid use disorder7
Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery7
Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the O7
Assessment of harm reduction receipt and infectious diseases outcomes in United States Veterans with opioid use disorder and history of injection drug use7
Naloxone prescriptions among patients with a substance use disorder and a positive fentanyl urine drug screen presenting to the emergency department7
Balancing public health and privacy rights: a mixed-methods study on disclosure obligations of people living with HIV to their partners in China7
A qualitative investigation of the feasibility and acceptability of lower risk gambling guidelines7
Harm reduction in the Heartland: public knowledge and beliefs about naloxone in Nebraska, USA7
The theory of preloading: A cognitive-behavioural motivational model7
Correction: Increasing access to screening for blood-borne viruses and sexually transmissible infections for Aboriginal and Torres Strait Islander Australians: evaluation of the Deadly Liver Mob progr7
Community-based drug checking at syringe service programs in New York City observe an increasing prevalence of xylazine from 2021 through 20247
Long-acting injectable depot buprenorphine from a harm reduction perspective in patients with ongoing substance use and multiple psychiatric comorbidities: a qualitative interview study7
HOME protocol for a national online survey of people who inject drugs7
Perceived harms and protective behavioural strategies among khat chewers: a qualitative study in Jimma, Ethiopia7
Rural community-based participatory research with families of people who use drugs: key considerations from a multi-provincial research partnership7
The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in a rural American state6
Correction: Drug use and sexual behaviors among women who inject drugs and use a syringe services program; Miami, Florida6
Decentralised same day test and treatment of hepatitis C levering existing peer support networks among men who inject drugs: feasibility and effectiveness6
Harm reduction practises for users of psychedelic drugs: a scoping review6
Treatment non-adherence among methadone maintenance patients and associated factors: a multicenter, cross-sectional study in Vietnam6
Xylazine awareness and attitudes among people who use drugs in Ohio, 2023–20246
Evaluation of the unregulated online kratom market in two east-central European countries: test purchase and analysis of potential toxicological consequences6
0.038150787353516